Landscapes / Targets
IL-17F
2 drugs act on IL-17F, in 7 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs2
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
Phase 3 | 4 Jan 2027Phase 3 trial completes | |||
| How it works | An antibody | ||||
| Next date | 4 Jan 2027 · Phase 3 trial completes | ||||
| Also tested for | Arthritis, Psoriatic, Hidradenitis Suppurativa | ||||
| Open drug page | |||||
Multi-specific immunoglobulin |
Phase 2 | 17 May 2027Phase 2 trial completes | |||
| How it works | An antibody built to latch onto two or more targets at once | ||||
| Next date | 17 May 2027 · Phase 2 trial completes | ||||
| Also tested for | Atopic Dermatitis, Non-cystic Fibrosis Bronchiectasis and 1 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 2 of 2 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026